215 related articles for article (PubMed ID: 18712473)
41. A BRCA2 mutation incorrectly mapped in the original BRCA2 reference sequence, is a common West Danish founder mutation disrupting mRNA splicing.
Thomassen M; Pedersen IS; Vogel I; Hansen TV; Brasch-Andersen C; Brasen CL; Crüger D; Sunde L; Nielsen FC; Jensen UB; Bisgaard ML; Borg A; Gerdes AM; Kruse TA
Breast Cancer Res Treat; 2011 Jul; 128(1):179-85. PubMed ID: 21184276
[TBL] [Abstract][Full Text] [Related]
42. Pathological splice mutations outside the invariant AG/GT splice sites of BRCA1 exon 5 increase alternative transcript levels in the 5' end of the BRCA1 gene.
Claes K; Vandesompele J; Poppe B; Dahan K; Coene I; De Paepe A; Messiaen L
Oncogene; 2002 Jun; 21(26):4171-5. PubMed ID: 12037674
[TBL] [Abstract][Full Text] [Related]
43. Genetic and histopathologic evaluation of BRCA1 and BRCA2 DNA sequence variants of unknown clinical significance.
Chenevix-Trench G; Healey S; Lakhani S; Waring P; Cummings M; Brinkworth R; Deffenbaugh AM; Burbidge LA; Pruss D; Judkins T; Scholl T; Bekessy A; Marsh A; Lovelock P; Wong M; Tesoriero A; Renard H; Southey M; Hopper JL; Yannoukakos K; Brown M; Easton D; Tavtigian SV; Goldgar D; Spurdle AB;
Cancer Res; 2006 Feb; 66(4):2019-27. PubMed ID: 16489001
[TBL] [Abstract][Full Text] [Related]
44. A novel BRCA2 mutation that segregates with breast and prostate cancer in a Spanish family.
Salgado J; Aramendía JM; Gutierrez C; Gil C; Robles M; García-Foncillas J
Breast Cancer Res Treat; 2010 May; 121(1):219-20. PubMed ID: 19288190
[TBL] [Abstract][Full Text] [Related]
45. The BRCA1 c.5434C->G (p.Pro1812Ala) variant induces a deleterious exon 23 skipping by affecting exonic splicing regulatory elements.
Gaildrat P; Krieger S; Théry JC; Killian A; Rousselin A; Berthet P; Frébourg T; Hardouin A; Martins A; Tosi M
J Med Genet; 2010 Jun; 47(6):398-403. PubMed ID: 20522429
[TBL] [Abstract][Full Text] [Related]
46. A functional polymorphism in the miR-146a gene and age of familial breast/ovarian cancer diagnosis.
Shen J; Ambrosone CB; DiCioccio RA; Odunsi K; Lele SB; Zhao H
Carcinogenesis; 2008 Oct; 29(10):1963-6. PubMed ID: 18660546
[TBL] [Abstract][Full Text] [Related]
47. Comprehensive prediction of mRNA splicing effects of BRCA1 and BRCA2 variants.
Mucaki EJ; Ainsworth P; Rogan PK
Hum Mutat; 2011 Jul; 32(7):735-42. PubMed ID: 21523855
[TBL] [Abstract][Full Text] [Related]
48. Identification of a novel in-frame deletion in BRCA2 and analysis of variants of BRCA1/2 in Italian patients affected with hereditary breast and ovarian cancer.
Vietri MT; Molinari AM; Laura De Paola M; Cantile F; Fasano M; Cioffi M
Clin Chem Lab Med; 2012 Dec; 50(12):2171-80. PubMed ID: 23096105
[TBL] [Abstract][Full Text] [Related]
49. The c.156_157insAlu BRCA2 rearrangement accounts for more than one-fourth of deleterious BRCA mutations in northern/central Portugal.
Peixoto A; Santos C; Rocha P; Pinheiro M; Príncipe S; Pereira D; Rodrigues H; Castro F; Abreu J; Gusmão L; Amorim A; Teixeira MR
Breast Cancer Res Treat; 2009 Mar; 114(1):31-8. PubMed ID: 18363094
[TBL] [Abstract][Full Text] [Related]
50. BRCA2 deep intronic mutation causing activation of a cryptic exon: opening toward a new preventive therapeutic strategy.
Anczuków O; Buisson M; Léoné M; Coutanson C; Lasset C; Calender A; Sinilnikova OM; Mazoyer S
Clin Cancer Res; 2012 Sep; 18(18):4903-9. PubMed ID: 22753590
[TBL] [Abstract][Full Text] [Related]
51. Heterogenic loss of the wild-type BRCA allele in human breast tumorigenesis.
King TA; Li W; Brogi E; Yee CJ; Gemignani ML; Olvera N; Levine DA; Norton L; Robson ME; Offit K; Borgen PI; Boyd J
Ann Surg Oncol; 2007 Sep; 14(9):2510-8. PubMed ID: 17597348
[TBL] [Abstract][Full Text] [Related]
52. Unclassified variants identified in BRCA1 exon 11: Consequences on splicing.
Anczuków O; Buisson M; Salles MJ; Triboulet S; Longy M; Lidereau R; Sinilnikova OM; Mazoyer S
Genes Chromosomes Cancer; 2008 May; 47(5):418-26. PubMed ID: 18273839
[TBL] [Abstract][Full Text] [Related]
53. BRCA1 p.Val1688del is a deleterious mutation that recurs in breast and ovarian cancer families from Northeast Italy.
Malacrida S; Agata S; Callegaro M; Casella C; Barana D; Scaini MC; Manoukian S; Oliani C; Radice P; Barile M; Menin C; D'Andrea E; Montagna M
J Clin Oncol; 2008 Jan; 26(1):26-31. PubMed ID: 18165637
[TBL] [Abstract][Full Text] [Related]
54. [Molecular analysis of genetic predispositions to breast cancer].
Coulet F; Godard V; Dumont C; Soubrier F
Bull Acad Natl Med; 1999; 183(8):1627-39; discussion 1639-41. PubMed ID: 10987054
[TBL] [Abstract][Full Text] [Related]
55. De novo Alu element insertions targeted to a sequence common to the BRCA1 and BRCA2 genes.
Teugels E; De Brakeleer S; Goelen G; Lissens W; Sermijn E; De Grève J
Hum Mutat; 2005 Sep; 26(3):284. PubMed ID: 16088935
[TBL] [Abstract][Full Text] [Related]
56. Molecular and clinical characterization of an in frame deletion of uncertain clinical significance in the BRCA2 gene.
Rath MG; Fathali-Zadeh F; Langheinz A; Tchatchou S; Voigtländer T; Heil J; Golatta M; Schott S; Drasseck T; Behnecke A; Burgemeister AL; Evers C; Bugert P; Junkermann H; Schneeweiss A; Bartram CR; Sohn C; Sutter C; Burwinkel B
Breast Cancer Res Treat; 2012 Jun; 133(2):725-34. PubMed ID: 22228431
[TBL] [Abstract][Full Text] [Related]
57. Polymorphisms in BRCA2 resulting in aberrant codon-usage and their analysis on familial breast cancer risk.
Yang R; Chen B; Hemminki K; Wappenschmidt B; Engel C; Sutter C; Ditsch N; Weber BH; Niederacher D; Arnold N; Meindl A; Bartram CR; Schmutzler RK; Burwinkel B
Breast Cancer Res Treat; 2009 Nov; 118(2):407-13. PubMed ID: 19229607
[TBL] [Abstract][Full Text] [Related]
58. Thorough in silico and in vitro cDNA analysis of 21 putative BRCA1 and BRCA2 splice variants and a complex tandem duplication in BRCA2 allowing the identification of activated cryptic splice donor sites in BRCA2 exon 11.
Baert A; Machackova E; Coene I; Cremin C; Turner K; Portigal-Todd C; Asrat MJ; Nuk J; Mindlin A; Young S; MacMillan A; Van Maerken T; Trbusek M; McKinnon W; Wood ME; Foulkes WD; Santamariña M; de la Hoya M; Foretova L; Poppe B; Vral A; Rosseel T; De Leeneer K; Vega A; Claes KBM
Hum Mutat; 2018 Apr; 39(4):515-526. PubMed ID: 29280214
[TBL] [Abstract][Full Text] [Related]
59. Novel complex genomic rearrangement of the BRCA1 gene.
Zikan M; Pohlreich P; Stribrna J; Kleibl Z; Cibula D
Mutat Res; 2008 Jan; 637(1-2):205-8. PubMed ID: 17868747
[TBL] [Abstract][Full Text] [Related]
60. Characterization of functional messenger RNA splice variants of BRCA1 expressed in nonmalignant and tumor-derived breast cells.
Lu M; Conzen SD; Cole CN; Arrick BA
Cancer Res; 1996 Oct; 56(20):4578-81. PubMed ID: 8840964
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
